Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality von Ishizawa, Jo, Zarabi, Sarah F., Davis, R. Eric, Halgas, Ondrej, Nii, Takenobu, Jitkova, Yulia, Zhao, Ran, St-Germain, Jonathan, Heese, Lauren E., Egan, Grace, Ruvolo, Vivian R., Barghout, Samir H., Nishida, Yuki, Hurren, Rose, Ma, Wencai, Gronda, Marcela, Link, Todd, Wong, Keith, Mabanglo, Mark, Kojima, Kensuke, Borthakur, Gautam, MacLean, Neil, Ma, Man Chun John, Leber, Andrew B., Minden, Mark D., Houry, Walid, Kantarjian, Hagop, Stogniew, Martin, Raught, Brian, Pai, Emil F., Schimmer, Aaron D., Andreeff, Michael

Volltext

Presence of Recurrent Somatic Mutations in Mesenchymal Stromal Cell Fractions Isolated from Acute Myeloid Leukemia As an Evidence of Clonality von Bhatti, Muzaffar, Kim, Taehyung, Warrington, Jenny, Ambalavanan, Amirthagowri, Zarabi, Sarah, Travas, Anthea, Kim, Jaeyoon John, Pyne, Danielle, Ketela, Troy, Arruda, Andrea, Minden, Mark D., Keating, Armand, Kim, Dennis Dong Hwan

Volltext

Dual Targeting of Mitochondrial Unfolded Protein Response and BCL2 in Acute Myeloid Leukemia von Zhao, Ran, Zarabi, Sarah, Nii, Takenobu, Halgas, Ondrej, Jitkova, Yulia, Ruvolo, Vivian, Heese, Lauren, Nishida, Yuki, Borthakur, Gautam M., Kojima, Kensuke, Stogniew, Martin, Oster, Wolfgang, Pai, Emil, Davis, Eric, Kantarjian, Hagop M., Schimmer, Aaron D, Andreeff, Michael, Ishizawa, Jo

Volltext

Abstract 2720: Mitochondrial ClpP-mediated proteolysis induces selective cancer cell lethality von Ishizawa, Jo, Zarabi, Sarah F., Davis, R Eric, Halgas, Ondrej, Nii, Takenobu, Jitkova, Yulia, Zhao, Ran, St-Germain, Jonathan, Heese, Lauren E., Egan, Grace, Ruvolo, Vivian R., Barghout, Samir H., Nishida, Yuki, Hurren, Rose, Ma, Wencai, Gronda, Marcela, Link, Todd, Wong, Keith, Mabanglo, Mark, Kojima, Kensuke, Borthakur, Gautam, MacLean, Neil, Ma, John Man Chun, Leber, Andrew B., Minden, Mark D., Houry, Walid, Kantarjian, Hagop, Stogniew, Martin, Raught, Brian, Pai, Emil F., Schimmer, Aaron D., Andreeff, Michael

Volltext

Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors von Jang, Hyeok-Jae, Woo, Young-Min, Naka, Kazuhito, Park, Jong-Ho, Han, Ho-Jae, Kim, Hee-Jin, Kim, Sun-Hee, Ahn, Jae-Sook, Kim, Taehyung, Kimura, Shinya, Zarabi, Sarah, Lipton, Jeffrey H., Minden, Mark D., Jung, Chul-Won, Kim, Hyeoung-Joon, Kim, Jong-Won, Kim, Dennis Dong Hwan

Volltext

A5280 - 3 years’ experience on Modified Duodenal Switch (MDS) A multicenter study throughout 36 month von Sabrudin, Sarah, Roslin, Mitchell, Allis, Debbie, Zarabi, Sharon, Pearlstein, Sarah, Cottam, Daniel, Zaveri, Hinali, Surve, Amit, Cottam, Austin, Enochs, Paul, Bull, Jaime

Volltext

3 years’ experience on Modified Duodenal Switch (MDS) A multicenter study throughout 36 month von Sabrudin, Sarah, Roslin, Mitchell, Allis, Debbie, Zarabi, Sharon, Pearlstein, Sarah, Cottam, Daniel, Zaveri, Hinali, Surve, Amit, Cottam, Austin, Enochs, Paul, Bull, Jaime

Volltext